Is it safe to stop lisinopril (ACE inhibitor) when starting Bactrim (trimethoprim‑sulfamethoxazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, stopping lisinopril to take Bactrim is NOT safe and NOT necessary

You should NOT stop lisinopril when starting Bactrim (trimethoprim-sulfamethoxazole). However, this combination requires careful monitoring due to a significant risk of life-threatening hyperkalemia.

The Core Issue: Hyperkalemia Risk

Both lisinopril (an ACE inhibitor) and Bactrim's trimethoprim component can independently raise potassium levels. When combined, they create a dangerous synergistic effect:

  • Trimethoprim acts like a potassium-sparing diuretic by blocking sodium channels in the distal nephron, similar to amiloride 1
  • ACE inhibitors reduce aldosterone, which normally promotes potassium excretion 2, 3
  • The combination increases hyperkalemia risk nearly 7-fold compared to other antibiotics in patients on ACE inhibitors 4

The FDA drug label explicitly warns: "In the literature, three cases of hyperkalemia in elderly patients have been reported after concomitant intake of BACTRIM and an angiotensin converting enzyme inhibitor" and recommends to "avoid concurrent use" 1.

What You Should Do Instead

Before Starting Bactrim:

  • Check baseline potassium and creatinine 2, 1
  • Assess kidney function (eGFR) - risk increases dramatically with renal insufficiency 5
  • Review the indication - consider alternative antibiotics when clinically appropriate 4, 6

If Bactrim is Necessary:

Continue the lisinopril BUT implement strict monitoring:

  1. Check potassium within 3-5 days of starting Bactrim 1
  2. Recheck at 7-10 days if treatment continues
  3. Stop Bactrim immediately if potassium rises above 5.5 mEq/L 1
  4. Ensure adequate hydration to prevent crystalluria 1

High-Risk Situations Requiring Extra Caution:

  • Renal insufficiency (eGFR <60 mL/min/1.73 m²) - 4.6-fold increased risk 5
  • Baseline potassium >4.5 mEq/L 7
  • Elderly patients 4, 6
  • Concurrent use of other potassium-raising drugs (spironolactone, NSAIDs) 1, 6
  • Diabetes or volume depletion 1

Consider Alternative Antibiotics

When treating common infections in patients on ACE inhibitors, safer alternatives include:

  • Amoxicillin - no increased hyperkalemia risk 4
  • Azithromycin - significantly safer profile 8
  • Cephalosporins - no potassium interaction

Bactrim should be reserved for situations where these alternatives are inappropriate based on culture data, allergy history, or specific infection type 9.

Why NOT to Stop Lisinopril

Abrupt ACE inhibitor withdrawal can cause clinical deterioration in patients with heart failure or hypertension 10, 3. The cardiovascular benefits of continuing lisinopril typically outweigh the hyperkalemia risk IF proper monitoring is implemented 11, 2.

Guidelines emphasize that ACE inhibitors should be temporarily suspended only during acute illness, severe volume depletion, or planned procedures - not routinely for antibiotic courses 12, 3.

Critical Warning Signs

Seek immediate medical attention if experiencing:

  • Muscle weakness or paralysis
  • Irregular heartbeat or palpitations
  • Nausea or confusion
  • Severe fatigue

These may indicate dangerous hyperkalemia requiring emergency treatment 1, 6.

The Bottom Line

The safest approach is to continue lisinopril with close potassium monitoring rather than stopping it. If monitoring cannot be ensured or the patient has multiple risk factors (especially renal insufficiency), choose a different antibiotic 1, 4, 8. The combination of ACE inhibitors and Bactrim has been associated with sudden death from severe hyperkalemia 6, making this a serious drug interaction that demands respect but doesn't automatically require stopping either medication.

References

Research

Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Guideline

kidney dysfunction in heart failure: core curriculum 2025.

American Journal of Kidney Diseases, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.